Basiliximab mode of action
1:06
Basiliximab mode of action
846 viewsJan 26, 2023
YouTubeAsif Biotech
Interleukin 2 and its role in Immunity | Basiliximab as IL2R antagonist | IL2 and T cell activation
5:52
Interleukin 2 and its role in Immunity | Basiliximab as IL2R antagonist | IL2 and T cell activation
5K viewsJun 18, 2024
YouTubeAnimated biology With arpan
Dr Wilky on a Study of Botensilimab Plus Balstilimab in Refractory Metastatic Sarcoma
0:59
Dr Wilky on a Study of Botensilimab Plus Balstilimab in Refractory Metastatic Sarcoma
138 viewsSep 13, 2024
YouTubeOncLive
Transplant Immunology (Part 1)
2:21
Transplant Immunology (Part 1)
9.9K viewsMay 28, 2019
YouTubeSurgEdVidz
The patient who received basiliximab (Simulect) just before and... | Filo
The patient who received basiliximab (Simulect) just before and... | Filo
10 months ago
askfilo.com
Dr Wilky on a Study of Botensilimab Plus Balstilimab in Refractory Metastatic Sarcoma | OncLive
Dr Wilky on a Study of Botensilimab Plus Balstilimab in Refractory Metastatic Sarcoma | OncLive
Sep 13, 2024
onclive.com
The new generation of B cell–targeting therapies for the treatment of autoimmune kidney diseases
The new generation of B cell–targeting therapies for the treatment of autoimmune kidney diseases
6.8K viewsJul 31, 2024
oup.com
Dr Wilky on the Study of Zalifrelimab, Balstilimab, and Doxorubicin in Soft Tissue Sarcoma | OncLive
Dr Wilky on the Study of Zalifrelimab, Balstilimab, and Doxorubicin in Soft Tissue Sarcoma | OncLive
Jun 27, 2023
onclive.com
Basiliximab is used to Prevent & Treat Rejection in Organ Transplantation
2:07
Basiliximab is used to Prevent & Treat Rejection in Organ Transplantation
1.8K viewsJul 30, 2019
YouTubeMedindia Videos
Rituximab: Uses and Mechanisms in B-Cell Malignancies
0:50
Rituximab: Uses and Mechanisms in B-Cell Malignancies
20.7K viewsJun 4, 2024
TikTokrxinsight
Dr Schlechter on the Potential Future Implications of Botensilimab and Balstilimab in MSS mCRC | OncLive
1:30
Dr Schlechter on the Potential Future Implications of Botensilimab and Balstilimab in MSS mCRC | OncLive
7 months ago
onclive.com
DLIx as a prognostic tool for LBCL patients receiving axi-cel
5:23
DLIx as a prognostic tool for LBCL patients receiving axi-cel
51 viewsJan 19, 2021
YouTubeVJHemOnc – Video Journal of Hematology & H…
Basiliximab Meaning
0:58
Basiliximab Meaning
2 viewsJan 15, 2016
DailymotionMeaning Book
Systemic Therapy Options for Basal Cell Carcinoma | OncLive
Systemic Therapy Options for Basal Cell Carcinoma | OncLive
Jul 1, 2022
onclive.com
Optimizing Maintenance Immunosuppressive Therapy in Kidney Transplantation
28:08
Optimizing Maintenance Immunosuppressive Therapy in Kidney Transplantation
5.5K viewsMar 18, 2021
YouTubePeerView CME
Rare breakthrough in advanced colorectal cancer treatment
1:26
Rare breakthrough in advanced colorectal cancer treatment
478 viewsSep 27, 2023
YouTubeAJE Video Bytes
UCB - New Bimekizumab Phase 3 Data
10:32
UCB - New Bimekizumab Phase 3 Data
1.2K viewsMay 14, 2021
YouTubeHPR
CHAPTER 313 - Transplantation in the Treatment of Renal Failure: Overview and Outcomes
32:42
CHAPTER 313 - Transplantation in the Treatment of Renal Failure: Overview and Outcomes
22 views2 months ago
YouTubeMED_NESS | MEDICAL BOOKS SIMPLIFIED
Bavituximab Mechanism of Action (MOA) Animation
1:34
Bavituximab Mechanism of Action (MOA) Animation
11.2K viewsMar 27, 2014
YouTubeXVIVO Scientific Animation
Many different BsAbs are in development. Their ability to target and activate specific immune effector cells and responses against tumors holds great promise as cancer therapy. Blinatumomab represents the first-in-class BiTE antibody in clinical use and provides a novel therapeutic option for patients with relapsed/refractory B-cell acute lymphoblastic leukemia - Learn more: http://bit.ly/2gIynJg | American Society of Clinical Oncology
1:36
Many different BsAbs are in development. Their ability to target and activate specific immune effector cells and responses against tumors holds great promise as cancer therapy. Blinatumomab represents the first-in-class BiTE antibody in clinical use and provides a novel therapeutic option for patients with relapsed/refractory B-cell acute lymphoblastic leukemia - Learn more: http://bit.ly/2gIynJg | American Society of Clinical Oncology
5.9K viewsDec 4, 2016
FacebookAmerican Society of Clinical Oncology
Rituximab & Belimumab EXPLAINED: Mechanisms of Action in Autoimmune Therapy (High-Yield Hematology)
4:31
Rituximab & Belimumab EXPLAINED: Mechanisms of Action in Autoimmune Therapy (High-Yield Hematology)
3.3K viewsJul 6, 2023
YouTubeFoxterrier
Organ Transplant Rejection & Immunosuppresants | PTCB Prep Guide
6:32
Organ Transplant Rejection & Immunosuppresants | PTCB Prep Guide
40 views4 months ago
YouTubePTCB Prep Guide
Patients with relapsed or refractory large B-cell lymphoma after first-line chemoimmunotherapy have a poor prognosis. Second-line treatment with the CAR T-cell therapy axi-cel may improve outcomes. New research findings are summarized in a short video. https://nej.md/3sS5510 | The New England Journal of Medicine
2:01
Patients with relapsed or refractory large B-cell lymphoma after first-line chemoimmunotherapy have a poor prognosis. Second-line treatment with the CAR T-cell therapy axi-cel may improve outcomes. New research findings are summarized in a short video. https://nej.md/3sS5510 | The New England Journal of Medicine
2.2K viewsFeb 16, 2022
FacebookThe New England Journal of Medicine
Basiliximab
27:27
Basiliximab
69 views7 months ago
YouTubeAbdelhamid Aboghanem Nephro Clinical Pearls
Real-world long-term outcomes of patients with LBCL treated with axi-cel
4:59
Real-world long-term outcomes of patients with LBCL treated with axi-cel
87 viewsApr 25, 2022
YouTubeVJHemOnc – Video Journal of Hematology & H…
Immunosuppresant Classification Mnemonics|| GPAT Lecture||NEET PG||Pharmacist|| Staff Nurse||NET JRF
8:27
Immunosuppresant Classification Mnemonics|| GPAT Lecture||NEET PG||Pharmacist|| Staff Nurse||NET JRF
22.5K viewsJul 23, 2020
YouTubeTutor Box
tacrolimus
1:52
tacrolimus
7K viewsFeb 1, 2022
YouTubeAir to air
Mechanism of action of proteasome inhibitors
4:05
Mechanism of action of proteasome inhibitors
3.1K viewsMay 26, 2016
YouTubeVJHemOnc – Video Journal of Hematology & H…
How Does Rituximab Work For B-cell Lymphoma? - Lymphoma Support Network
3:19
How Does Rituximab Work For B-cell Lymphoma? - Lymphoma Support Network
45 views7 months ago
YouTubeLymphoma Support Network
Transplant & Immunosuppressant Drugs | Chapter 33 – Pharmacology (12th)
36:52
Transplant & Immunosuppressant Drugs | Chapter 33 – Pharmacology (12th)
2 months ago
YouTubeLast Minute Lecture
See more